Human Genome Epidemiology Literature Finder
|
Records 1 - 18 (of 18 Records) |
| Query Trace: Neoplasms and KDM5C[original query] |
|---|
| Exome sequencing identifies frequent mutation of the SWI/SNF complex gene PBRM1 in renal carcinoma. Nature 2011 1 469 (7331): 539-42. Varela Ignacio, Tarpey Patrick, Raine Keiran, Huang Dachuan, Ong Choon Kiat, Stephens Philip, Davies Helen, Jones David, Lin Meng-Lay, Teague Jon, Bignell Graham, Butler Adam, Cho Juok, Dalgliesh Gillian L, Galappaththige Danushka, Greenman Chris, Hardy Claire, Jia Mingming, Latimer Calli, Lau King Wai, Marshall John, McLaren Stuart, Menzies Andrew, Mudie Laura, Stebbings Lucy, Largaespada David A, Wessels L F A, Richard Stephane, Kahnoski Richard J, Anema John, Tuveson David A, Perez-Mancera Pedro A, Mustonen Ville, Fischer Andrej, Adams David J, Rust Alistair, Chan-on Waraporn, Subimerb Chutima, Dykema Karl, Furge Kyle, Campbell Peter J, Teh Bin Tean, Stratton Michael R, Futreal P Andr |
| Clinical and pathologic impact of select chromatin-modulating tumor suppressors in clear cell renal cell carcinoma. European urology 2012 Sep . Hakimi AA, Chen YB, Wren J, Gonen M, Abdel-Wahab O, Heguy A, Liu H, Takeda S, Tickoo SK, Reuter VE, Voss MH, Motzer RJ, Coleman JA, Cheng EH, Russo P, Hsieh JJ |
| Radiogenomics of clear cell renal cell carcinoma: preliminary findings of The Cancer Genome Atlas-Renal Cell Carcinoma (TCGA-RCC) Imaging Research Group. Abdominal imaging 2015 Aug 40 (6): 1684-92. Shinagare Atul B, Vikram Raghu, Jaffe Carl, Akin Oguz, Kirby Justin, Huang Erich, Freymann John, Sainani Nisha I, Sadow Cheryl A, Bathala Tharakeswara K, Rubin Daniel L, Oto Aytekin, Heller Matthew T, Surabhi Venkateswar R, Katabathina Venkat, Silverman Stuart |
| Gender Specific Mutation Incidence and Survival Associations in Clear Cell Renal Cell Carcinoma (CCRCC). PloS one 2015 10 (10): e0140257. Ricketts Christopher J, Linehan W Marst |
| Genomic Biomarkers of a Randomized Trial Comparing First-line Everolimus and Sunitinib in Patients with Metastatic Renal Cell Carcinoma. European urology 2016 Oct . Hsieh James J, Chen David, Wang Patricia I, Marker Mahtab, Redzematovic Almedina, Chen Ying-Bei, Selcuklu S Duygu, Weinhold Nils, Bouvier Nancy, Huberman Kety H, Bhanot Umesh, Chevinsky Michael S, Patel Parul, Pinciroli Patrizia, Won Helen H, You Daoqi, Viale Agnes, Lee William, Hakimi A Ari, Berger Michael F, Socci Nicholas D, Cheng Emily H, Knox Jennifer, Voss Martin H, Voi Maurizio, Motzer Robert |
| Characterizing recurrent and lethal small renal masses in clear cell renal cell carcinoma using recurrent somatic mutations. Urologic oncology 2017 11 37 (1): 12-17. Manley Brandon J, Reznik Ed, Ghanaat Mazyar, Kashan Mahyar, Becerra Maria F, Casuscelli Jozefina, Tennenbaum Daniel, Redzematovic Almedina, Carlo Maria I, Sato Yusuke, Arcila Maria, Voss Martin H, Feldman Darren R, Motzer Robert J, Russo Paul, Coleman Jonathan, Hsieh James J, Hakimi Ari |
| Impact of Patient Age on Molecular Alterations of Left-Sided Colorectal Tumors. The oncologist 2018 7 24 (3): 319-326. Puccini Alberto, Lenz Heinz-Josef, Marshall John L, Arguello David, Raghavan Derek, Korn W Michael, Weinberg Benjamin A, Poorman Kelsey, Heeke Arielle L, Philip Philip A, Shields Anthony F, Goldberg Richard M, Salem Mohamed |
| Comprehensive Genomic Profiling of Metastatic Tumors in a Phase 2 Biomarker Study of Everolimus in Advanced Renal Cell Carcinoma. Clinical genitourinary cancer 2018 5 16 (5): 341-348. Gao Xin, Jegede Opeyemi, Gray Connor, Catalano Paul J, Novak Jesse, Kwiatkowski David J, McKay Rana R, George Daniel J, Choueiri Toni K, McDermott David F, Signoretti Sabina, Bhatt Rupal |
| Genomically annotated risk model for advanced renal-cell carcinoma: a retrospective cohort study. The Lancet. Oncology 2018 12 19 (12): 1688-1698. Voss Martin H, Reising Albert, Cheng Yuan, Patel Parul, Marker Mahtab, Kuo Fengshen, Chan Timothy A, Choueiri Toni K, Hsieh James J, Hakimi A Ari, Motzer Robert |
| Mutations and Response to Rapalogs in Patients with Metastatic Renal Cell Carcinoma. Molecular cancer therapeutics 2019 Oct . Nassar Amin H, Hamieh Lana, Gray Kathryn P, Thorner Aaron R, Fay Andre P, Lasseter Kathryn D, Abou Alaiwi Sarah, Nuzzo Pier Vitale, Flippot Ronan, Krajewski Katherine M, Signoretti Sabina, Choueiri Toni K, Kwiatkowski David |
| Genetic and epigenetic profiling indicates the proximal tubule origin of renal cancers in end-stage renal disease. Cancer science 2020 8 111 (11): 4276-4287. Ishihara Hiroki, Yamashita Satoshi, Liu Yu-Yu, Hattori Naoko, El-Omar Omar, Ikeda Takashi, Fukuda Hironori, Yoshida Kazuhiko, Takagi Toshio, Taneda Sekiko, Kondo Tsunenori, Nagashima Yoji, Tanabe Kazunari, Ushijima Toshika |
| A Somatic Mutation Signature Predicts the Best Overall Response to Anti-programmed Cell Death Protein-1 Treatment in Epidermal Growth Factor Receptor/Anaplastic Lymphoma Kinase-Negative Non-squamous Non-small Cell Lung Cancer. Frontiers in medicine 2022 9 808378. Peng Jie, Xiao Lushan, Zou Dan, Han Lij |
| Evaluation of a seven gene mutational profile as a prognostic factor in a population-based study of clear cell renal cell carcinoma. Scientific reports 2022 4 12 (1): 6478. van de Pol Jeroen A A, Ferronika Paranita, Westers Helga, van Engeland Manon, Terpstra Martijn M, Smits Kim M, de Lange Kim, van den Brandt Piet A, Sijmons Rolf H, Schouten Leo J, Kok Kla |
| Identification of Survival-Specific Genes in Clear Cell Renal Cell Carcinoma Using a Customized Next-Generation Sequencing Gene Panel. Journal of personalized medicine 2022 Jan 12 (1): . Hwang Jia, Kim Heeeun, Han Jinseon, Lee Jieun, Hong Sunghoo, Kim Saewoong, Yoon Sungjoo Kim, Choi Keonwoo, Yang Jihoon, Park Unsang, Kim Kwangjoong, Yim Kwangil, Kim Yuil, Choi Yeongj |
| PBRM1 and KDM5C cooperate to define high-angiogenesis tumors and increased antiangiogenic response in renal cancer. American journal of cancer research 2023 6 13 (5): 2116-2125. María Santos, Javier Lanillos, Eduardo Caleiras, Carlos Valdivia, Juan M Roldan-Romero, Nuria Laínez, Javier Puente, Benoit Beuselinck, Stéphane Oudard, Jessica Zucman-Rossi, Paloma Navarro, Mercedes Robledo, Daniel Castellano, Guillermo de Velasco, Jesús García-Donas, Cristina Rodriguez-Anto |
| Identifying survival of pan-cancer patients under immunotherapy using genomic mutation signature with large sample cohorts. Journal of molecular medicine (Berlin, Germany) 2023 11 . Liuchao Zhang, Yuanyuan Wang, Liuying Wang, Meng Wang, Shuang Li, Jia He, Jianxin Ji, Kang Li, Lei C |
| Sex-specific survival gene mutations are discovered as clinical predictors of clear cell renal cell carcinoma. Scientific reports 2024 7 14 (1): 15800. Jia Hwang, Hye Eun Lee, Jin Seon Han, Moon Hyung Choi, Sung Hoo Hong, Sae Woong Kim, Ji Hoon Yang, Unsang Park, Eun Sun Jung, Yeong Jin Ch |
| Mutational profile of primary clear cell renal cell carcinoma predicts recurrence and potential candidacy for adjuvant immune checkpoint inhibition. F1000Research 2024 6 12 918. Panagiotis J Vlachostergios, Maria Papathanassiou, Maria Anagnostou, Eleni Thodou, Ioannis Tamposis, Lampros Mitrakas, Ioannis Zachos, George K Koukoulis, Maria Samara, Vassilios Tzortz |
- Page last reviewed:Feb 1, 2024
- Content source: